-
1 Comment
Jiangsu Apon Medical Technology Co., Ltd is currently in a long term downtrend where the price is trading 9.7% below its 200 day moving average.
From a valuation standpoint, the stock is 5.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 9.1.
Jiangsu Apon Medical Technology Co., Ltd's total revenue sank by 7.3% to $110M since the same quarter in the previous year.
Its net income has dropped by 5.8% to $25M since the same quarter in the previous year.
Finally, its free cash flow fell by 69.0% to $19M since the same quarter in the previous year.
Based on the above factors, Jiangsu Apon Medical Technology Co., Ltd gets an overall score of 1/5.
| Industry | Medical Instruments & Supplies |
|---|---|
| Sector | Healthcare |
| Exchange | SHE |
| CurrencyCode | CNY |
| ISIN | CNE100003FV4 |
| Dividend Yield | 0.3% |
|---|---|
| Beta | 0.21 |
| Market Cap | 3B |
| PE Ratio | None |
| Target Price | None |
Jiangsu Apon Medical Technology Co., Ltd. engages in the research and development, production, and sale of medical devices in China. Its principal products include microcomputer injection pumps, disposable injection pumps, wireless analgesia management systems, and pulse oximeters, as well as medical devices, such as sensors in the field of pain management and nasal care sprayers in the field of nasal care. Jiangsu Apon Medical Technology Co., Ltd. was founded in 2001 and is headquartered in Nantong, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300753.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
